Loading…

Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions

The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these r...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceuticals (Basel, Switzerland) Switzerland), 2022-07, Vol.15 (8), p.948
Main Authors: Sánchez-Sancho, Francisco, Escolano, Marcos, Gaviña, Daniel, Csáky, Aurelio G., Sánchez-Roselló, María, Díaz-Oltra, Santiago, del Pozo, Carlos
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733
cites cdi_FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733
container_end_page
container_issue 8
container_start_page 948
container_title Pharmaceuticals (Basel, Switzerland)
container_volume 15
creator Sánchez-Sancho, Francisco
Escolano, Marcos
Gaviña, Daniel
Csáky, Aurelio G.
Sánchez-Roselló, María
Díaz-Oltra, Santiago
del Pozo, Carlos
description The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these restrictions, two main approaches have been devised. The first one involves the modification of the conventional components of the Biginelli reaction and the second one refers to the postmodification of the Biginelli products. Both strategies have been extensively revised in this manuscript. Regarding the first one, initially, the modification of one of the components was covered. Although examples of modifications of the three of them were described, by far the modification of the keto ester counterpart was the most popular approach, and a wide variety of different enolizable carbonylic compounds were used; moreover, changes in two or the three components were also described, broadening the substitution of the final dihydropyrimidines. Together with these modifications, the use of Biginelli adducts as a starting point for further modification was also a very useful strategy to decorate the final heterocyclic structure.
doi_str_mv 10.3390/ph15080948
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0e49479b26a845c3b63db2a42b68aad2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0e49479b26a845c3b63db2a42b68aad2</doaj_id><sourcerecordid>2706272207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733</originalsourceid><addsrcrecordid>eNpdkd9rFDEQgIMotlZf_AsWfKnFrfmdnT4I9tS2UBCsgm8hm2Rvc-4lZ7In3H_f1CtqfZph5puPYQahlwSfMgb47WYkAncYePcIHRJOedtRrh7_kx-gZ6WsMBaKcPIUHTCJ6wjIQ_T9Zhfn0ZdQmjQ07A1vP4Rx53La7HJYBxfi8TyG9DpF3yxSnE2IIS6bG2uGIU3urDkPyxD9NIV2Cj9888UbO4cUy3P0ZDBT8S_u4xH69unj18Vle_354mrx_rq1nMPcWnDcc2qNcsz2IJnAQ0-B98LxQSjZMSFZB44oAGNA0poDtr6TIKBTjB2hq73XJbPSm7q0yTudTNC_CykvtclzsJPX2HPgCnoqTceFZb1krqeG0152xjhaXe_2rs22X3tnfZyzmR5IH3ZiGPUy_dLACRMEquD4XpDTz60vs16HYut1TPRpWzRVWEmMFcEVffUfukrbHOup7ihJFaVYVepkT9mcSsl--LMMwfru-frv89ktfACfEg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2706272207</pqid></control><display><type>article</type><title>Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions</title><source>PubMed (Medline)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Sánchez-Sancho, Francisco ; Escolano, Marcos ; Gaviña, Daniel ; Csáky, Aurelio G. ; Sánchez-Roselló, María ; Díaz-Oltra, Santiago ; del Pozo, Carlos</creator><creatorcontrib>Sánchez-Sancho, Francisco ; Escolano, Marcos ; Gaviña, Daniel ; Csáky, Aurelio G. ; Sánchez-Roselló, María ; Díaz-Oltra, Santiago ; del Pozo, Carlos</creatorcontrib><description>The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these restrictions, two main approaches have been devised. The first one involves the modification of the conventional components of the Biginelli reaction and the second one refers to the postmodification of the Biginelli products. Both strategies have been extensively revised in this manuscript. Regarding the first one, initially, the modification of one of the components was covered. Although examples of modifications of the three of them were described, by far the modification of the keto ester counterpart was the most popular approach, and a wide variety of different enolizable carbonylic compounds were used; moreover, changes in two or the three components were also described, broadening the substitution of the final dihydropyrimidines. Together with these modifications, the use of Biginelli adducts as a starting point for further modification was also a very useful strategy to decorate the final heterocyclic structure.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph15080948</identifier><identifier>PMID: 36015096</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>3,4-dihydropyrimidinones ; Acids ; Aldehydes ; Analgesics ; Antihypertensives ; Biginelli ; biological activity ; Cancer ; Catalysis ; Enzymes ; Hydrogen bonds ; multicomponent reactions ; privileged structures ; R&amp;D ; Research &amp; development ; Review ; Solvents</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (8), p.948</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733</citedby><cites>FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733</cites><orcidid>0000-0002-2888-2231 ; 0000-0002-4771-5885</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2706272207/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2706272207?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Sánchez-Sancho, Francisco</creatorcontrib><creatorcontrib>Escolano, Marcos</creatorcontrib><creatorcontrib>Gaviña, Daniel</creatorcontrib><creatorcontrib>Csáky, Aurelio G.</creatorcontrib><creatorcontrib>Sánchez-Roselló, María</creatorcontrib><creatorcontrib>Díaz-Oltra, Santiago</creatorcontrib><creatorcontrib>del Pozo, Carlos</creatorcontrib><title>Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions</title><title>Pharmaceuticals (Basel, Switzerland)</title><description>The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these restrictions, two main approaches have been devised. The first one involves the modification of the conventional components of the Biginelli reaction and the second one refers to the postmodification of the Biginelli products. Both strategies have been extensively revised in this manuscript. Regarding the first one, initially, the modification of one of the components was covered. Although examples of modifications of the three of them were described, by far the modification of the keto ester counterpart was the most popular approach, and a wide variety of different enolizable carbonylic compounds were used; moreover, changes in two or the three components were also described, broadening the substitution of the final dihydropyrimidines. Together with these modifications, the use of Biginelli adducts as a starting point for further modification was also a very useful strategy to decorate the final heterocyclic structure.</description><subject>3,4-dihydropyrimidinones</subject><subject>Acids</subject><subject>Aldehydes</subject><subject>Analgesics</subject><subject>Antihypertensives</subject><subject>Biginelli</subject><subject>biological activity</subject><subject>Cancer</subject><subject>Catalysis</subject><subject>Enzymes</subject><subject>Hydrogen bonds</subject><subject>multicomponent reactions</subject><subject>privileged structures</subject><subject>R&amp;D</subject><subject>Research &amp; development</subject><subject>Review</subject><subject>Solvents</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkd9rFDEQgIMotlZf_AsWfKnFrfmdnT4I9tS2UBCsgm8hm2Rvc-4lZ7In3H_f1CtqfZph5puPYQahlwSfMgb47WYkAncYePcIHRJOedtRrh7_kx-gZ6WsMBaKcPIUHTCJ6wjIQ_T9Zhfn0ZdQmjQ07A1vP4Rx53La7HJYBxfi8TyG9DpF3yxSnE2IIS6bG2uGIU3urDkPyxD9NIV2Cj9888UbO4cUy3P0ZDBT8S_u4xH69unj18Vle_354mrx_rq1nMPcWnDcc2qNcsz2IJnAQ0-B98LxQSjZMSFZB44oAGNA0poDtr6TIKBTjB2hq73XJbPSm7q0yTudTNC_CykvtclzsJPX2HPgCnoqTceFZb1krqeG0152xjhaXe_2rs22X3tnfZyzmR5IH3ZiGPUy_dLACRMEquD4XpDTz60vs16HYut1TPRpWzRVWEmMFcEVffUfukrbHOup7ihJFaVYVepkT9mcSsl--LMMwfru-frv89ktfACfEg</recordid><startdate>20220730</startdate><enddate>20220730</enddate><creator>Sánchez-Sancho, Francisco</creator><creator>Escolano, Marcos</creator><creator>Gaviña, Daniel</creator><creator>Csáky, Aurelio G.</creator><creator>Sánchez-Roselló, María</creator><creator>Díaz-Oltra, Santiago</creator><creator>del Pozo, Carlos</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2888-2231</orcidid><orcidid>https://orcid.org/0000-0002-4771-5885</orcidid></search><sort><creationdate>20220730</creationdate><title>Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions</title><author>Sánchez-Sancho, Francisco ; Escolano, Marcos ; Gaviña, Daniel ; Csáky, Aurelio G. ; Sánchez-Roselló, María ; Díaz-Oltra, Santiago ; del Pozo, Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>3,4-dihydropyrimidinones</topic><topic>Acids</topic><topic>Aldehydes</topic><topic>Analgesics</topic><topic>Antihypertensives</topic><topic>Biginelli</topic><topic>biological activity</topic><topic>Cancer</topic><topic>Catalysis</topic><topic>Enzymes</topic><topic>Hydrogen bonds</topic><topic>multicomponent reactions</topic><topic>privileged structures</topic><topic>R&amp;D</topic><topic>Research &amp; development</topic><topic>Review</topic><topic>Solvents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Sancho, Francisco</creatorcontrib><creatorcontrib>Escolano, Marcos</creatorcontrib><creatorcontrib>Gaviña, Daniel</creatorcontrib><creatorcontrib>Csáky, Aurelio G.</creatorcontrib><creatorcontrib>Sánchez-Roselló, María</creatorcontrib><creatorcontrib>Díaz-Oltra, Santiago</creatorcontrib><creatorcontrib>del Pozo, Carlos</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Sancho, Francisco</au><au>Escolano, Marcos</au><au>Gaviña, Daniel</au><au>Csáky, Aurelio G.</au><au>Sánchez-Roselló, María</au><au>Díaz-Oltra, Santiago</au><au>del Pozo, Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><date>2022-07-30</date><risdate>2022</risdate><volume>15</volume><issue>8</issue><spage>948</spage><pages>948-</pages><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these restrictions, two main approaches have been devised. The first one involves the modification of the conventional components of the Biginelli reaction and the second one refers to the postmodification of the Biginelli products. Both strategies have been extensively revised in this manuscript. Regarding the first one, initially, the modification of one of the components was covered. Although examples of modifications of the three of them were described, by far the modification of the keto ester counterpart was the most popular approach, and a wide variety of different enolizable carbonylic compounds were used; moreover, changes in two or the three components were also described, broadening the substitution of the final dihydropyrimidines. Together with these modifications, the use of Biginelli adducts as a starting point for further modification was also a very useful strategy to decorate the final heterocyclic structure.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>36015096</pmid><doi>10.3390/ph15080948</doi><orcidid>https://orcid.org/0000-0002-2888-2231</orcidid><orcidid>https://orcid.org/0000-0002-4771-5885</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1424-8247
ispartof Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (8), p.948
issn 1424-8247
1424-8247
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0e49479b26a845c3b63db2a42b68aad2
source PubMed (Medline); Publicly Available Content Database (Proquest) (PQ_SDU_P3)
subjects 3,4-dihydropyrimidinones
Acids
Aldehydes
Analgesics
Antihypertensives
Biginelli
biological activity
Cancer
Catalysis
Enzymes
Hydrogen bonds
multicomponent reactions
privileged structures
R&D
Research & development
Review
Solvents
title Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A16%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%203,4-Dihydropyrimidin(thio)one%20Containing%20Scaffold:%20Biginelli-like%20Reactions&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=S%C3%A1nchez-Sancho,%20Francisco&rft.date=2022-07-30&rft.volume=15&rft.issue=8&rft.spage=948&rft.pages=948-&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph15080948&rft_dat=%3Cproquest_doaj_%3E2706272207%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2706272207&rft_id=info:pmid/36015096&rfr_iscdi=true